'Generic industry' presentation slideshows

Standards of Patentability and Opposition Procedures: India Patent Act & Novartis v. India

Standards of Patentability and Opposition Procedures: India Patent Act & Novartis v. India. Professor Brook K. Baker Health GAP Northeastern University School of Law, Program on Human Rights and the Global Economy UKZN IP and Access to Medicines 2010.

585 views • 32 slides

GENERIC MEDICINES IN EUROPE An Overall Assessment

462 views • 30 slides

COMPLUSORY LICENSING Focus on public Health Sector

COMPLUSORY LICENSING Focus on public Health Sector. Speaker Mohammed Zaka-ur-Rehman. CEO Schazoo Zaka (Pvt.) Ltd. The Schazoo Laboratories (Pvt) Ltd. Zaka Healthcare Ltd. Chairman WTO committee of PPMA. Standing Committee IPR LCCI. Former Chairman PPMA.

400 views • 24 slides

Gudbjorg Edda Eggertsdottir President EGA, President Iceland & Strategic Projects, Actavis Rome, 17 June 2013

Gudbjorg Edda Eggertsdottir President EGA, President Iceland & Strategic Projects, Actavis Rome, 17 June 2013 . EGA - introduction. Established in 1993 Based in Brussels International non-profit organisation under Belgian law (ASBL). Pan European (not only EU)

304 views • 19 slides

FDA Critical Path Initiative: A Generic Industry Perspective

FDA Critical Path Initiative: A Generic Industry Perspective. Shahid Ahmed American Pharmaceutical Partners on Behalf of the Generic Pharmaceutical Association. Outline. Overview of Generic Industry Critical Path Initiative Concepts Relevance to the Generic Industry

286 views • 10 slides